Could a daily brain zapping helmet ease autism symptoms in kids?
NCT ID NCT07276555
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether a device called NeuroCytotron, which sends low-energy magnetic pulses to specific brain areas, can safely improve social communication and reduce repetitive behaviors in children with autism. 256 children aged 3 to 12 will be randomly assigned to receive either real or sham (placebo) treatments for 28 days. Neither the families nor the researchers will know who gets the real treatment, and the main goal is to see if the active group shows greater improvement on standard autism rating scales.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NeuroCytotron device (low-energy pulsed electromagnetic fields)
What this could lead to
If it works, this could offer a new, noninvasive treatment option to ease core autism symptoms like social communication difficulties and repetitive behaviors in children.
What could go wrong
This is an early-stage trial with no prior human data, so the treatment may not work better than placebo. Risks include discomfort from lying still, anxiety, and possible side effects from sedation needed for MRI scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NeuroCytonix Mexico
San Pedro Garza García, Nuevo León, 66224, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
NeuroCytonix, Inc.
Rockville, Maryland, 20850, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••